- Home
- Products
Pemazyre (Pemigatinib)
Pemazyre (Pemigatinib)
- Medicine Name: Pemazyre
- Generic Name: Pemigatinib
- Dosage Form & Strength: Tablets – 4.5 mg, 9 mg, 13.5 mg
- Manufactured By: Incyte Corporation
Pemazyre is a fibroblast growth factor receptor (FGFR) inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion or rearrangement.
Recommended Dosage:
- 13.5 mg orally once daily for 14 days, followed by 7 days off (21-day cycle)
- Continue until disease progression or unacceptable toxicity
- Tablets should be taken whole, with or without food, around the same time daily
- Do not crush, chew, split, or dissolve
- Missed dose/vomiting: Do not retake; continue with next scheduled dose
Eye Toxicity (RPED): May cause vision changes such as floaters or blurring. Perform baseline and periodic ophthalmic exams with OCT
Hyperphosphatemia: Monitor serum phosphate. Begin a low phosphate diet for levels > 5.5 mg/dL and initiate medical intervention for levels > 7 mg/dL
Fetal Harm Risk: May cause fetal harm. Advise use of contraception during treatment and for 1 week after final dose (both females and males with partners of reproductive potential)
Documents Required to Import Pemazyre to India:
- Valid prescription from a certified oncologist
- Diagnostic test reports (confirming FGFR2 fusion)
- Patient’s government-issued identity proof
Order Confirmation:
Confirmed upon submission of above documents and import permit (if required)
Available Across:
Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Kolkata, Ahmedabad, Pune, Noida, Gurgaon, Lucknow, Jaipur, Ludhiana, Chandigarh, Jammu, Srinagar and other major cities in India
📞 To Order / Enquire Price:
- Call/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds sources Pemazyre from certified suppliers in the USA, Europe, Canada, and Australia. We ensure:
- Named Patient Import (NPI) compliance
- Prescription validation by licensed pharmacists
- Dispatch from our fulfillment center in Ambernath, Thane District
- Global delivery with full documentation
What is the generic name of Pemazyre®?
Pemigatinib
Who manufactures Pemazyre®?
Incyte Corporation
Is Pemazyre® FDA approved?
Yes, approved on April 17, 2020
What cancers does Pemazyre® treat?
Unresectable/metastatic cholangiocarcinoma with FGFR2 gene rearrangement
What dosage forms are available?
Tablets – 4.5 mg, 9 mg, and 13.5 mg
Common side effects?
Nail toxicity, hyperphosphatemia, alopecia, diarrhea, dry mouth, nausea, stomatitis, vision disturbances, fatigue, and decreased appetite
Storage Instructions:
Store at 20°C to 25°C (68°F to 77°F); excursions permitted 15°C to 30°C
Can I buy Pemazyre online in India?
Yes. Global Rare Meds facilitates legal access under the Named Patient Program
How much does Pemazyre cost in India?
Pricing is case-specific. Contact us for a quote:
📲 +91-99675 15602 | ✉️ info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
